Evaluation of Vitrase as an Adjuvant to Increase Absorption and Dispersion of Other Injected Anesthetics

Phase 4

Completed

• Conditions: Pain

• Registration Number: NCT00198549
• Lead Sponsor: Bausch & Lomb Incorporated

Brief Summary

The purpose of this study is to evaluate Vitrase as an adjuvant to increase absorption and dispersion of other injected anesthetics

Detailed Description

Not available

Study Timeline

• Study Start: 2004-09
• Primary Completion: 2005-01
• Study Completion: 2005-03
• Study First Submitted: 2005-09-13
• Study First Submitted QC: 2005-09-13
• Study First Posted: 2005-09-20
• Status Verified: 2013-03
• Last Update Submitted: 2013-03-15
• Last Update Posted: 2013-03-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• Scheduled for an ophthalmic surgical procedure

Exclusion Criteria

• Known allergy to bee venom

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
To evaluate physician acceptance of efficacy of Vitrase as an adjuvant to increase absorption and dispersion of anesthetics used for ophthalmic surgical procedures

Secondary Outcome Measures

Name	Time	Method
To determine physician usage of and satisfaction with Vitrase in the 6200 USP unit vial

Trial Locations

Locations (1)

Cincinnati Eye Institute; 🇺🇸 Cincinnati, Ohio, United States